BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Ten Up as Vapourtec Goes With the Flow


10/14/2013 8:35:25 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

October 14, 2013 -- Bury St Edmunds (Suffolk) based Vapourtec has reached the twin milestones of 10 years in business and being featured in 100 peer reviewed publications.

Vapourtec design and manufacture flow chemistry systems for a wide variety of sectors across the globe including education, pharmaceutical and industry and their technology has been cited as playing a pivotal part in recent major research breakthroughs.

Established in 2003, Vapourtec has developed a flourishing international market for its technology with sales across much of the developed world including USA, China, Japan, Singapore and India.

Founder and MD Duncan Guthrie commented: “It’s very pleasing to look back over the past decade and see the progress we’ve made.

“We have sold our flow chemistry units to the top ten global pharmaceutical companies with most returning to purchase multiple systems and in 2011 we established a strategic presence in Malaysia to service the Asian market which now represents our biggest area of growth.

“We have also become the first firm in our field to have been featured in 100 peer reviewed publications submitted by our customers and Vapourtec’s systems have recently played a key role in research that has identified more efficient manufacturing of key drugs including Tamoxifen for Breast Cancer.

“Flow chemistry as a process represents the future and we are actively involved in research with many major college and university chemistry departments around the world. It’s vital that we educate future generations of chemists as to the many advantages on using flow chemistry.

“These are very exciting times for Vapourtec with our systems continuing to be at the cutting edge of chemistry breakthroughs,” added Duncan.

For more details visit www.vapourtec.com

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

Vapourtec
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES